Clinical Trial

Advancing Integrated Therapies for Gaucher Disease

Name: Advancing Integrated Therapies for Gaucher Disease — clinical trial record (NCT07758816)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to better understand the natural history, clinical outcomes, and biological features of Gaucher disease in patients receiving standard medical care

Trial Details

NCT Number	NCT07758816
Lead Sponsor	Yale University Collaborators: Sanofi-Yale External Research Collaboration
Conditions	Gaucher Disease
Enrollment	30 participants
Start Date	2026-05-06
Primary Completion	2030-09 (estimated)
Study Completion	2030-09 (estimated)
Updated on ClinicalTrials.gov	2026-08-11